Amwill Health Care IPO is scheduled to open for subscription on February 5, 2025, and will close on February 7, 2025. This book-built issue aims to raise approximately ₹59.98 crores, consisting of a fresh issue of ₹48.88 crores and an offer for sale of up to 10,00,000 equity shares, each with a face value of ₹10. The price band for the IPO is set between ₹105 to ₹111 per share.
The IPO allocation includes 35% for retail investors, 50% for QIBs (Qualified Institutional Buyers), and 15% for HNIs (High Net-Worth Individuals). Retail investors can invest a minimum of ₹1,05,000 for a lot size of 1,000 shares, while HNIs are required to invest a minimum of ₹2,10,000 for 2 lots (2,000 shares).
The allotment of shares is expected to be finalized on February 10, 2025, with the IPO scheduled to list on the NSE on February 12, 2025.
Overview of Contents
Amwill Health Care IPO Overview
| Category | Details |
|---|---|
| IPO Subscription Start Date | February 5, 2025 |
| IPO Subscription End Date | February 7, 2025 |
| Nominal Value of Shares | ₹10 per Equity Share |
| IPO Price Range | ₹105 to ₹111 per share |
| Total Issue Amount | Approx ₹59.98 Crores |
| Amount Raised Through Fresh Issue | Approx ₹48.88 Crores |
| Offer for Sale | Approx 10,00,000 Equity Shares |
| IPO Type | Book Built Issue |
| Market Listing | BSE SME |
| Retail Investor Allocation | Not more than 35% |
| Qualified Institutional Buyer (QIB) Allocation | Not more than 50% |
| Non-Institutional Investor (NII) Allocation | Not more than 15% |
| Expected Listing Date | February 12, 2025 |
| Nominal Value | ₹10 per share |
| Price Range | ₹105 to ₹111 per share |
| Lot Size | 1,200 Shares |
| Total Shares on Offer | 54,03,600 shares (aggregating up to ₹59.98 Cr) |
| Fresh Issue Shares | 44,03,600 shares (aggregating up to ₹48.88 Cr) |
| Offer for Sale Shares | 10,00,000 shares of ₹10 (aggregating up to ₹11.10 Cr) |
| IPO Type | Book Built Issue |
| Listing Exchange | BSE SME |
| Shares Pre-Issue | 1,56,00,000 shares |
| Shares Post-Issue | 2,00,03,600 shares |
| Market Maker Allocation | 2,71,200 shares |
| DRHP | Click here |
| RHP | Click here |
Amwill Health Care IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹1,33,200 |
| Retail (Max) | 1 | 1200 | ₹1,33,200 |
| HNI (Min) | 2 | 2,400 | ₹2,66,400 |
Amwill Healthcare IPO Dates
| Event | Date |
|---|---|
| IPO Subscription Start | Wednesday, February 5, 2025 |
| IPO Subscription End | Friday, February 7, 2025 |
| Allotment Finalization | Monday, February 10, 2025 |
| Refund Process Initiation | Tuesday, February 11, 2025 |
| Shares Credit to Demat Accounts | Tuesday, February 11, 2025 |
| Listing Date on Exchange | Wednesday, February 12, 2025 |
| UPI Mandate Confirmation Deadline | 5:00 PM on Friday, February 7, 2025 |
Amwill Healthcare IPO Promoter Holding
The Promoters of the Company are namely Anand Gandhi and Tarun Gandhi.
| Share Holding Pre Issue | 97.00% |
| Share Holding Post Issue | To Be Updated |
Amwill Healthcare IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 20.00% of the Net Issue |
| Retail Shares Offered | Not less than 40.00% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 40.00% of the Net Issue |
About Amwill Healthcare IPO
Amwill Health Care Limited, established in August 2017, is a prominent derma-cosmetic development firm specializing in the creation of dermatological and cosmeceutical products. The company partners with contract manufacturers, distributors, and third-party product development agencies, which enhances its capabilities in manufacturing, packaging, and distribution. Amwill Health Care’s product portfolio focuses on developing solutions for a wide range of dermatological issues such as acne, fungal infections, anti-aging, vitiligo, and more.
The company has successfully built a strong presence in the southern Indian markets, particularly in Karnataka, Andhra Pradesh, and Telangana, and is focused on expanding further. Amwill Health Care’s business model emphasizes high-quality product development, leveraging its extensive expertise and tie-ups with reliable manufacturers. This approach, combined with an asset-light business strategy, positions the company as a leading player in the derma-cosmetic sector.
Amwill Health Care is committed to offering effective skincare solutions by formulating products with pure, high-quality ingredients. The company’s recent launch of seven new products further strengthens its portfolio, ensuring it meets the diverse needs of its growing customer base.
Objects of the Issue
- To be finalized upon determination of the offer price and updated in the prospectus before filing with the ROC.
- Up to 25% of the gross proceeds will be allocated for general corporate purposes.
Amwill Health Care IPO Company Financial Information
| Year | Revenue (₹ in Crores) | Expense (₹ in Crores) | Profit After Tax (₹ in Crores) | Assets (₹ in Crores) |
|---|---|---|---|---|
| 2021 | 18.00 | 19.03 | 1.00 | 1.02 |
| 2022 | 27.61 | 24.28 | 2.57 | 3.75 |
| 2023 | 30.17 | 26.11 | 3.11 | 4.3 |
| December 2023 | 35.79 | 21.28 | 11.00 | 14.67 |
Amwill Health Care IPO Valuation – FY2023
| KPI | Values |
|---|---|
| ROE: | 67.67% |
| ROCE: | 83.32% |
| EBITDA Margin: | 14.24% |
| PAT Margin: | 10.32% |
| Debt to equity ratio: | NA |
| Earning Per Share (EPS): | ₹2.00 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 67.67% |
| Net Asset Value (NAV): | ₹2.95 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Amwill Health Care IPO | 2.00 | NA | 67.67% | 2.95 | 30.17 Cr. |
| Vaishali Pharma Limited | 6.26 | 28.47 | 16.29% | 38.43 | 69.66 Cr. |
| Trident Lifeline Limited | 6.23 | 26.81 | 13.18% | 39.68 | 31.69 Cr. |
Amwill Health Care IPO Review
- Canara Bank –
- DRChoksey FinServ –
- Emkay Global –
- Hem Securities –
- IDBI Capital –
- Marwadi Shares –
- Nirmal Bang –
- SBICAP Securities –
- Sharekhan –
- SMC Global –
- Sushil Finance –
- Swastika Investmart –
- Ventura Securities –
- Geojit –
- Reliance Securities –
- Capital Market –
- BP Wealth –
- ICICIdirect –
- Choice Broking –
Amwill Health Care IPO Registrar
BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Centre, Mahakali
Caves Road, Andheri East, Mumbai – 400 093
Phone: +91 22 6263 8200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
IPO Lead Managers aka Merchant Bankers
- Unistone Capital Private Limited
- Bigshare Services Private Limited
Company Address
Amwill Health Care IPO Limited
No. 157, 1st Floor, 2nd Main, 3rd Cross Chamrajpet,
Bangalore – 560 018, Karnataka
Phone: +91 804 302 6281
E-mail: amwill@amwillhealthcare.com
Website: www.amwillhealthcare.com
Amwill Health Care IPO FAQs
What is the IPO Open Date?
The Amwill Health Care IPO will open on February 5, 2025.
When is the IPO Close Date?
The IPO will close on February 7, 2025.
What is the Price Band for the IPO?
The price band is ₹105 to ₹111 per share.
What is the Issue Size of the IPO?
The issue size is approximately ₹59.98 crores.
What is the Lot Size for the IPO?
The lot size is 1,200 shares.
What is the Listing Date for the IPO?
The IPO is expected to list on February 12, 2025, on the BSE SME platform.
What is the Retail Quota for the IPO?
The retail quota is up to 35%.
What is the QIB Quota for the IPO?
The QIB quota is up to 50%.
What is the NII Quota for the IPO?
The NII quota is up to 15%.
What is the Face Value of the Shares?
The face value is ₹10 per share.